Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer

Published:2005-03 Issue:3 Volume:27 Page:327-335
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Jansman Frank G.A.,Idzinga Froukje S.F.,Smit Willem M.,de Graaf Jacques C.,Coenen Jules L.L.M.,Sleijfer Dirk Th.,Brouwers Jacobus R.B.J.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Clinically relevant fluorouracil + leucovorin interactions in patients with colorectal cancer;Jansman;Pharm Weekbl.,2004

2. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment;Grothey;J Clin Oncol.,2004

3. New systemic frontline treatment for metastatic colorectal carcinoma;Braun;Cancer,2004

4. Campto [product information],2003

5. Eloxatin [product information],2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular fundamentals of drug interactions in the therapy of colorectal cancer;Postępy Higieny i Medycyny Doświadczalnej;2014-03-04

2. Potential Interactions with Anticancer Agents: A Cross-Sectional Study;Chemotherapy;2013

3. Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer;International Journal of Clinical Oncology;2012-05-26

4. Consensus-Based Evaluation of Clinical Significance and Management of Anticancer Drug Interactions;Clinical Therapeutics;2011-03

5. Drug interactions in oncology: how common are they?;Annals of Oncology;2009-12